Critically, selective inhibitors of CDK8/19 Mediator kinase, a pleiotropic regulator of transcriptional reprogramming, prevent anoikis adaptation and metastasis in ovarian cancer models. This evidence concerns the gene CDK8 and ovarian carcinoma.